171 related articles for article (PubMed ID: 15324739)
1. Therapeutic manipulation of iNKT cells in autoimmunity: modes of action and potential risks.
Mars LT; Novak J; Liblau RS; Lehuen A
Trends Immunol; 2004 Sep; 25(9):471-6. PubMed ID: 15324739
[TBL] [Abstract][Full Text] [Related]
2. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L; Gabriel CL; Parekh VV; Van Kaer L
Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases.
Miyake S; Yamamura T
Int Rev Immunol; 2007; 26(1-2):73-94. PubMed ID: 17454265
[TBL] [Abstract][Full Text] [Related]
4. Immunoregulation of autoimmunity by natural killer T cells.
Linsen L; Somers V; Stinissen P
Hum Immunol; 2005 Dec; 66(12):1193-202. PubMed ID: 16690406
[TBL] [Abstract][Full Text] [Related]
5. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation.
Gigli G; Caielli S; Cutuli D; Falcone M
Immunology; 2007 Nov; 122(3):409-17. PubMed ID: 17617156
[TBL] [Abstract][Full Text] [Related]
6. Invariant NKT cells and tolerance.
Nowak M; Stein-Streilein J
Int Rev Immunol; 2007; 26(1-2):95-119. PubMed ID: 17454266
[TBL] [Abstract][Full Text] [Related]
7. Understanding the behavior of invariant NKT cells in autoimmune diseases.
Yamamura T; Sakuishi K; Illés Z; Miyake S
J Neuroimmunol; 2007 Nov; 191(1-2):8-15. PubMed ID: 17905445
[TBL] [Abstract][Full Text] [Related]
8. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometry for natural killer T cells: multi-parameter methods for multifunctional cells.
Metelitsa LS
Clin Immunol; 2004 Mar; 110(3):267-76. PubMed ID: 15047204
[TBL] [Abstract][Full Text] [Related]
10. alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles.
Van Kaer L
Nat Rev Immunol; 2005 Jan; 5(1):31-42. PubMed ID: 15630427
[TBL] [Abstract][Full Text] [Related]
11. The role of iNKT cells in development of bronchial asthma: a translational approach from animal models to human.
Akbari O
Allergy; 2006 Aug; 61(8):962-8. PubMed ID: 16867051
[TBL] [Abstract][Full Text] [Related]
12. Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway.
Miellot A; Zhu R; Diem S; Boissier MC; Herbelin A; Bessis N
Eur J Immunol; 2005 Dec; 35(12):3704-13. PubMed ID: 16304639
[TBL] [Abstract][Full Text] [Related]
13. Generation and sustained expansion of mouse spleen invariant NKT cell lines with preserved cytokine releasing capacity.
Molling JW; Moreno M; van der Vliet HJ; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
J Immunol Methods; 2007 Apr; 322(1-2):70-81. PubMed ID: 17343874
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic strategy for multiple sclerosis targeting NK and NKT cells].
Yamamura T
Rinsho Shinkeigaku; 2001 Dec; 41(12):1162-4. PubMed ID: 12235827
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells.
Uemura Y; Liu TY; Narita Y; Suzuki M; Nakatsuka R; Araki T; Matsumoto M; Iwai LK; Hirosawa N; Matsuoka Y; Murakami M; Kimura T; Hase M; Kohno H; Sasaki Y; Ichihara Y; Ishihara O; Kikuchi H; Sakamoto Y; Jiao SC; Senju S; Sonoda Y
J Immunol; 2009 Jul; 183(1):201-8. PubMed ID: 19542431
[TBL] [Abstract][Full Text] [Related]
16. In vitro expanded human invariant natural killer T-cells promote functional activity of natural killer cells.
Moreno M; Molling JW; von Mensdorff-Pouilly S; Verheijen RH; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
Clin Immunol; 2008 Oct; 129(1):145-54. PubMed ID: 18707922
[TBL] [Abstract][Full Text] [Related]
17. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood.
Jing Y; Gravenstein S; Chaganty NR; Chen N; Lyerly KH; Joyce S; Deng Y
Exp Gerontol; 2007 Aug; 42(8):719-32. PubMed ID: 17368996
[TBL] [Abstract][Full Text] [Related]
18. The in vivo response of invariant natural killer T cells to glycolipid antigens.
Parekh VV; Lalani S; Van Kaer L
Int Rev Immunol; 2007; 26(1-2):31-48. PubMed ID: 17454263
[TBL] [Abstract][Full Text] [Related]
19. Role of invariant natural killer T cells in immune regulation and as potential therapeutic targets in autoimmune disease.
Van Kaer L
Expert Rev Clin Immunol; 2006 Sep; 2(5):745-57. PubMed ID: 20477630
[TBL] [Abstract][Full Text] [Related]
20. Regulation of type 1 diabetes by NKT cells.
Novak J; Griseri T; Beaudoin L; Lehuen A
Int Rev Immunol; 2007; 26(1-2):49-72. PubMed ID: 17454264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
